DK1368022T3 - Anvendelse af en flaske indeholdende en oxaliplatinoplösning - Google Patents

Anvendelse af en flaske indeholdende en oxaliplatinoplösning

Info

Publication number
DK1368022T3
DK1368022T3 DK02700095T DK02700095T DK1368022T3 DK 1368022 T3 DK1368022 T3 DK 1368022T3 DK 02700095 T DK02700095 T DK 02700095T DK 02700095 T DK02700095 T DK 02700095T DK 1368022 T3 DK1368022 T3 DK 1368022T3
Authority
DK
Denmark
Prior art keywords
bottle containing
oxaliplatin solution
oxaliplatin
cytostatic
activity
Prior art date
Application number
DK02700095T
Other languages
English (en)
Inventor
Houssam Ibrahim
Ross Blundell
Martin Gray
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4513891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1368022(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Application granted granted Critical
Publication of DK1368022T3 publication Critical patent/DK1368022T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK02700095T 2001-03-02 2002-03-04 Anvendelse af en flaske indeholdende en oxaliplatinoplösning DK1368022T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3892001 2001-03-02
PCT/CH2002/000133 WO2002069959A1 (fr) 2001-03-02 2002-03-04 Dispositif de conditionnement d'une solution d'oxaliplatine

Publications (1)

Publication Number Publication Date
DK1368022T3 true DK1368022T3 (da) 2007-10-01

Family

ID=4513891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02700095T DK1368022T3 (da) 2001-03-02 2002-03-04 Anvendelse af en flaske indeholdende en oxaliplatinoplösning

Country Status (10)

Country Link
US (2) US20040220078A1 (da)
EP (1) EP1368022B1 (da)
AT (1) ATE365037T1 (da)
DE (2) DE60220766T2 (da)
DK (1) DK1368022T3 (da)
ES (1) ES2287238T3 (da)
FI (1) FI7753U1 (da)
PT (1) PT1368022E (da)
SI (1) SI1368022T1 (da)
WO (1) WO2002069959A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
RU2372089C2 (ru) * 2007-12-26 2009-11-10 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМУ Росздрава) Способ лечения больных колоректальным раком с метастазами в печень
CA2953350C (en) 2014-06-23 2019-11-26 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
BR112018000254A2 (pt) 2015-07-07 2018-09-04 H Lundbeck As inibidores de pde9 com cadeia principal de imidazotriazinona e cadeia principal de imidazopirazinona para o tratamento de doenças periféricas
AU2017292650A1 (en) 2016-07-06 2018-12-13 H. Lundbeck A/S PDE9 inhibitors for treatment of peripheral diseases
SI3630772T1 (sl) 2017-05-26 2024-05-31 Cardurion Pharmaceuticals, Inc., Postopki izdelave in uporabe zaviralcev pde9
EP3801526B1 (en) 2018-05-25 2023-12-27 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one
CN112996512B (zh) 2018-08-31 2025-01-03 卡都瑞恩医药公司 用于治疗镰状细胞病的pde9抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566600A (en) * 1984-07-05 1986-01-28 Owens-Illinois, Inc. Plastic container
CA1232215A (en) * 1984-10-23 1988-02-02 Maud Frizon Sphereoidal bottle with stopper
JP3547755B2 (ja) * 1994-08-08 2004-07-28 デビオファーム・エス・アー オキサリプラティヌムの医薬的に安定な製剤
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
US6866857B1 (en) * 1998-10-14 2005-03-15 Debiopharm S.A. Oxalipatinum preparation packaging

Also Published As

Publication number Publication date
US20080108697A1 (en) 2008-05-08
DE60220766D1 (de) 2007-08-02
US20040220078A1 (en) 2004-11-04
DE20221679U1 (de) 2006-11-23
PT1368022E (pt) 2007-10-01
SI1368022T1 (sl) 2007-10-31
FI7753U1 (fi) 2008-01-30
ATE365037T1 (de) 2007-07-15
FIU20070189U0 (fi) 2007-05-07
DE60220766T2 (de) 2008-03-06
WO2002069959A1 (fr) 2002-09-12
ES2287238T3 (es) 2007-12-16
EP1368022A1 (fr) 2003-12-10
EP1368022B1 (fr) 2007-06-20

Similar Documents

Publication Publication Date Title
FI7753U1 (fi) Laite oksaliplatiiniliuoksen pakkaamiseksi
DK1411118T3 (da) Celleproliferationsinhibitorer indeholdende anti-glypican-3-antistof
DE60232017D1 (de) Flüssige zusammensetzung aus faktor vii polypeptiden
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
ATE333290T1 (de) Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
CY1108137T1 (el) Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα
DK1326630T3 (da) Anvendelse af GLP-2-peptider
ATE295829T1 (de) Verwendung von biologisch aktivem glas zum schneiden von biologisch aktivem glas
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
MEP8209A (en) Modified factor viii
SE0301653D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
ATE458057T1 (de) Varianten der faktor-vii- oder -viia-gla-domäne
IS6986A (is) Lyfjasamsetning í vökvaformi
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
SE0102716D0 (sv) Novel compounds
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
MXPA03010861A (es) COMPOSICION TOPICA QUE COMPRENDE UN AGENTE DE UNION COSMeTICO TRANSESTRUCTURADO Y ACTIVADO.
ES2045768T3 (es) Composiciones topicas que contienen defibrotida.
FR2825273B1 (fr) Composition pour le traitement des signes cutanes du vieillissement
AR037131A1 (es) Formulaciones de jarabe de ribavirina
SE0103276D0 (sv) Anordning för administrering av salva till en hudyta
ATE374022T1 (de) Oxaliplatinlösungskonzentrate